• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20001 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     HAYES, Inc. Topoisomerase II alpha (TOP2A) testing to predict response to treatment of breast cancer
2006     NIHR Horizon Scanning Centre (NIHR HSC) Topotecan (hycamtin) for carcinoma of the cervix: horizon scanning technology ultra-orphan note
2010     NIHR Health Technology Assessment programme Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix
2009     National Institute for Health and Clinical Excellence (NICE) Topotecan for the treatment of recurrent and stage IVB cervical cancer
2009     National Institute for Health and Clinical Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer
2006     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2015     NIHR Health Technology Assessment programme Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent or refractory ovarian cancer: a systematic review and economic evaluation
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Total ankle arthroplasty
2010     HAYES, Inc. Total ankle replacement
2007     HAYES, Inc. Total ankle replacement
2011     HAYES, Inc. Total ankle replacement
2002     HAYES, Inc. Total artificial heart, temporary biventricular support device
2005     HAYES, Inc. Total artificial heart, temporary or permanent biventricular support device
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Total contact casts for diabetic foot ulcers: cost-effectiveness
2000     Medical Services Advisory Committee (MSAC) Total ear reconstruction
2013     Health Quality Ontario (HQO) Total hip arthroplasty versus hemiarthroplasty for displaced femoral neck fractures: a rapid review
1996     University of York Total hip replacement
2015     NIHR Health Technology Assessment programme Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation
2014     HAYES, Inc. Total hip replacement with hard on hard prostheses
2004     HAYES, Inc. Total hip replacement with hard-on-hard prostheses
2006     HAYES, Inc. Total hip resurfacing arthroplasty
2006     HAYES, Inc. Total hip resurfacing arthroplasty
2003     Agency for Healthcare Research and Quality (AHRQ) Total knee replacement
2005     Medical Advisory Secretariat (MAS) Total knee replacement: an evidence-based analysis
2007     Haute Autorite de sante (HAS) Total lumbar disc replacement
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Total Mesorectal Excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer - primary research
2010     HAYES, Inc. Total Pancreatectomy with Autologous Islet Cell Transplantation (TP/AIT) for chronic pancreatitis
2015     HAYES, Inc. Total pancreatectomy with islet autotransplantation for chronic pancreatitis
2013     Institute of Health Economics (IHE) Total prosthetic replacement of the temporomandibular joint: a rapid evidence assessment and economic analysis
2005     HAYES, Inc. Total sialic acid and lipid-associated sialic acid as tumor markers
2020     NIHR Health Technology Assessment programme Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT
2016     Agency for Healthcare Research and Quality (AHRQ) Total Worker Health®
2010     HAYES, Inc. Total wrist arthroplasty
2005     National Institute for Clinical Excellence (NICE) Totally endoscopic robotically assisted coronary artery bypass grafting
2006     HAYES, Inc. Totally extraperitoneal (TEP) laparoscopic surgery for treatment of athletic pubalgia
2002     The Swedish Council on Health Technology Assessment (SBU) Touch massage for dementia - early assessment briefs (ALERT)
2002     Centre for Clinical Effectiveness (CCE) Tourniquets in phlebotomy
1998     Health Council of the Netherlands Gezondheidsraad (GR) Toward the effective use of benzodiazepines
2015     NIHR Health Services and Delivery Research programme Towards a framework for enhancing procurement and supply chain management practice in the NHS: lessons for managers and clinicians from a synthesis of the theoretical and empirical literature
2013     NIHR Health Services and Delivery Research programme Towards a framework for enhancing the performance of NHS boards: a synthesis of the evidence about board governance, board effectiveness and board development
2015     Belgian Health Care Knowledge Centre (KCE) Towards a guided and phased introduction of high-risk medical devices in Belgium
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamin A
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamin D
2009     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamins and minerals
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards an optimal use of folic acid
2004     NIHR Health Technology Assessment programme Towards efficient guidelines: 1. When to develop guidelines- systematic review
2003     NIHR Health Technology Assessment programme Towards efficient guidelines: how to monitor guideline use in primary care
2013     NIHR Health Services and Delivery Research programme Towards equitable commissioning for our multiethnic society: a mixed-methods qualitative investigation of evidence utilisation by strategic commissioners and public health managers
2005     NIHR Health Technology Assessment programme Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2016     NIHR Health Services and Delivery Research programme Towards improved decision support in the assessment and management of pain for people with dementia in hospital: a systematic meta-review and observational study
2008     Health Council of the Netherlands Gezondheidsraad (GR) Towards maintaining an optimum iodine intake
2010     NIHR Health Technology Assessment programme Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives
2010     HAYES, Inc. Townes-Brocks Syndrome (TBS)
2011     HAYES, Inc. TP53 (p53) testing for Li-Fraumeni Syndrome (LFS)
2012     HAYES, Inc. TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2011     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for advanced and/or metastatic translocation-related sarcomas - first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for relapsed ovarian cancer
2006     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for second and third-line treatment of soft tissue sarcoma: horizon scanning technology ultra-orphan note
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trabectedin (Yondelis) for second-line recurrent platinum-sensitive ovarian cancer
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trabectedin (Yondelis®) for advanced soft tissue sarcoma
2003     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin for soft tissue sarcoma - horizon scanning review
2010     NIHR Health Technology Assessment programme Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
2010     National Institute for Health and Clinical Excellence (NICE) Trabectedin for the treatment of advanced soft tissue sarcoma
2011     NIHR Health Technology Assessment programme Trabectedin for the treatment of relapsed ovarian cancer
2011     National Institute for Health and Clinical Excellence (NICE) Trabectedin for the treatment of relapsed ovarian cancer
2009     HAYES, Inc. Trabectome (NeoMedix Corp.) for treatment of glaucoma
2021     Center for Evidence-based Practice (CEP) Tracheostomy or endotracheal tubes and subglottic suctioning
2014     HAYES, Inc. Tracleer (Bosentan; Actelion Pharmaceuticals Ltd.) for treatment of digital ulcers in patients with scleroderma
2002     NIHR Health Technology Assessment programme Training for patient and public ('consumer') involvement in health and social care research: a study of training provision and participants' experiences
2018     NIHR Health Technology Assessment programme Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT
2002     Agency for Healthcare Research and Quality (AHRQ) Training of clinicians for public health events relevant to bioterrorism preparedness
2004     Agency for Healthcare Research and Quality (AHRQ) Training of hospital staff to respond to a mass casualty incident
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol compared with opioids for pain: a review of addiction potential
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012     NIHR Horizon Scanning Centre (NIHR HSC) Trametinib in combination with dabrafenib for V600 BRAF positive advanced malignant melanoma – first line
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines
2019     NIHR Health Technology Assessment programme Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT
2002     New Zealand Health Technology Assessment (NZHTA) Trans-gender reassignment surgery
2013     HAYES, Inc. Transabdominal Cervical Cerclage (TAC) for the prevention of miscarriage
2004     Medical Services Advisory Committee (MSAC) Transanal endoscopic microsurgery
2007     HAYES, Inc. Transanal endoscopic microsurgery for rectal carcinoma
2009     HAYES, Inc. Transanal endoscopic microsurgery for rectal carcinoma
2013     HAYES, Inc. Transanal hemorrhoidal dearterialization
2010     HTA Database, Centre for Reviews and Dissemination, University of York Transarterial chemoembolization for palliation of unresectable liver metastases from colorectal cancer (Protocol for a systematic review)
2012     HAYES, Inc. Transarterial chemoembolization plus radiofrequency ablation for liver cancer
2013     HAYES, Inc. Transarterial embolization with embozene microspheres (CeloNova BioSciences Inc.) for treatment of hepatocellular carcinoma and other liver tumors
2012     HAYES, Inc. Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2020     Malaysian Health Technology Assessment (MaHTAS) Transbronchial cryobiopsy for lung biopsy in interstitial lung disease
2012     New Zealand National Health Committee (NHC) Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2021     Agency for Care Effectiveness (ACE) Transcatheter aortic valve implantation (TAVI) for patients with symptomatic severe aortic stenosis
2011     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults
2014     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk
2014     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery
2011     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults. This evidence note updates evidence note 33 published in March 2011
2018     Agenzia nazionale per i servizi sanitari regionali (Agenas) Transcatheter aortic valve implantation (TAVI) for the treatment of patients at intermediate risk [EUnetHTA collaborative assessment OTCA06]
2020     Health Technology Wales (HTW) Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2013     Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2012     Medical Advisory Secretariat (MAS) Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B)